Metrum Research Group, LLC Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2020
NCT04519567
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Metrum Research Group, LLC